I
nfantile hemangiomas (IHs) are the most common tumor of infancy, with a prevalence of 10%. 1 If noticed at birth (20%Y30%), only precursor lesions such as telangiectasia or a blanched area are present.
2Y4
Infantile hemangiomas more typically appear during the first 6 months of life and immediately undergo growth during a proliferation phase that lasts 3 months on average. 4, 5 They are located superficially, deeply, or combined superficially and deeply. 5, 6 Infantile hemangiomas are not painful unless they ulcerate, which happens predominately during the proliferation phase in 16% of cases. 7 The proliferation phase is followed by an involution phase that sets in at an average age between 8 and 12 months. During this phase, the cellularity, size, and turgidity decreases and the color fades to a gray hue, usually starting in the center of the tumor. 8 Once started, this regression progresses at a consistent rate, resulting in complete resolution by the age of 5 years in 50% of children, and by the age of 7 years in 70%. In 93% of children with IH, the diagnosis can be made based on the clinical features by the use of the classification of Mulliken and Glowacki that was modified and adopted by the International Society for Study of Vascular Anomalies. 9, 10 In these cases, a ''wait and watch'' policy may be adopted or, when indicated by secondary symptoms, treatment should start. 5 In the remaining 7%, additional investigations such as ultrasonography, magnetic resonance imaging (MRI), or pathological examination need to be performed to differentiate IH from other benign or malignant tumors. 11 Frieden et al 12, 13 recently recorded a comprehensive benign and malignant differential diagnosis of IH (Table 1) . They cautioned that their list of diagnosis did not exclude the possibility that other, as yet unreported IH mimics exists. 13 During the last decade, we were confronted with malignant IH mimics that have not been reported to date. Furthermore, Frieden et al did not illustrate all of the malignant mimics they suggested. In case of misdiagnosis of a malignancy as an IH, the ''wait and watch'' policy leads to delay or omission of optimal treatment. Therefore, we report on our patients with a malignancy that was initially presented under the diagnosis of IH.
MATERIALS AND METHODS
Approval for this retrospective study was obtained from the Committee on Clinical Investigation at the Academic Medical Center in Amsterdam, the Netherlands. The medical records of all children younger than 18 years, who were initially referred with the diagnosis of IH to the Department of Plastic, Reconstructive and Hand Surgery in the Academic Medical Center from April 2003 through December 2009, were assessed. From these, we extracted the definitive diagnosis and the sex, age of onset, and age at referral of the child. The age of onset was defined as the month of life in which the tumor was first noticed. In cases where the tumor presented at birth, this age was recorded as 0 month.
The complete diagnostic pathway of anamnesis, physical examination, all types of investigations (eg, MRI or ultrasound), and the pathological examination of the tumor was reconstructed in cases where the definitive diagnosis was a malignancy. For this subgroup, we calculated the delay of the definitive diagnosis defined as the period between the initial presentation of the skin anomaly that was incorrectly labeled as IH and the initiation of further investigation because of doubt regarding this initial diagnosis.
Results are presented in descriptive statistics. The KruskalWallis test, an analysis of variance test with a post hoc test (Tukey HSD), was applied to compare the age at onset of the skin anomaly and that at referral in children with IH with those in the children with other definitive diagnoses. A 2-tailed value of P G 0.05 was considered as statistically significant. Statistical analysis was performed using the SPSS software package (version 16.0; SPSS Inc, Chicago, Ill).
RESULTS

Differential Diagnosis and Demographic Characteristics
The referral diagnosis of IH was recorded for 423 children. This diagnosis was confirmed in 377 (89%) of these children. Thirty-nine of the other 46 children were rediagnosed with a single or combined form of vascular malformations (n = 31 or 7%) or other benign anomalies (n = 8 or 2%) ( Table 2) . Malignant diagnoses were reached in the remaining 7 (2%) children. These consisted of a rhabdomyosarcoma (n = 2), a sarcoma (n = 1), a poorly differentiated round and spool cell sarcoma (n = 1), a nerve sheath sarcoma (n = 1), a dermatofibrosarcoma protuberans (n = 1), or a lymphoma (n = 1) (Figs. 1 and 2).
Two hundred forty-three (64%) of the 377 children with an IH, 18 (58%) of the 31 children with a vascular malformation, 3 (38%) of the 8 patients with another benign tumor, and 5 (71%) of the 7 patients with a malignancy were female.
The median age of onset in children with IH was 4 months (range, 1Y9 months) and the median age of these children at referral was 6 months (range, 1Y15 months). These ages at onset and at referral differed significantly with those of children with a vascular malformation (P G 0.000 and P G 0.000, respectively) or another benign tumor (P G 0.001 and P G 0.001, respectively), but not with those of children with a malignancy (P = 0.340 and P = 0.705, respectively) ( Table 2 ).
Workup to Referral of the Alleged IH
In 4 of the 7 children (cases C, D, F, and G), false initial diagnostic conclusions were reached by the referring physician after anamnesis and physical examination. In 2 of these children (cases F and G), the ultrasonography ordered by their physician had been inconclusive.
In 2 of the other children (cases A and B), the false initial diagnosis reached after anamnesis and physical examination where, even, supported by ultrasonography.
The 1 remaining child (case E) had had multiple investigations elsewhere because of doubt regarding the initial diagnosis of IH. These had been inconclusive and the child was referred to us for a second opinion.
Workup to Definitive Diagnosis of Malignancies
After referral, we additionally performed ultrasonographies in 3 children (cases A, C, and F) and MRIs in 6 children (cases A, B, C, D, F, and G). In 1 case (D), plain film radiography and computed tomographic (CT) scan were executed to assess the extension of the anomaly.
The ultrasonography was consistent with IH in 1 case (A) and indecisive in another (C). In the remaining case (F), the ultrasonography was not consistent with IH and MRI was advised. The MRI was consistent with IH in 1 case (A) and indecisive in another (B). It raises suspicion of malignancy in the remaining cases (D, C, F, and G). The plain film radiography and CT scan provided information on the extension of the tumor, but not on its character.
The ultrasonography, plain film radiography, MRI, and MRangiography previously performed in case E were reassessed by our team. On the basis of these and the clinical presentation, it was concluded that the anomaly was not an IH.
Biopsies for pathological examination were obtained and led to the definitive diagnosis in all children.
After the definitive diagnosis was reached, 5 plain film radiographies, 3 CT scans, and 3 scintigraphies were made to exclude metastasis of the malignancy.
Delay to Definitive Diagnosis of Malignancies
The 3 children with a congenital malignancy were referred immediately after birth and no delay was observed. The mean delay of 
This examination was inconclusive. The slowly growing tumor on the forehead had turned from light blue to more reddish blue over the first month. Starting at the age of 2 months, the tumor showed ulceration and started bleeding continuously and the boy was first seen by our team at age 4.5 months. Ultrasonography excluded an IH and a MRI and biopsy were performed. The biopsy revealed a poorly differentiated round and spool cell malignancy. The boy died because of pulmonary metastasis at the age of 10.5 months. The delay had been 4 months. referral in the remaining 4 children with a malignancy was 11 months (range, 0Y37 months) ( Table 3 ).
DISCUSSION Diagnostic Pitfalls of IH
Because IH is a diagnosis that defines a benign vascular tumor with a typical clinical course, 9 this diagnosis can be reached based solely on anamnesis and physical examination in 93% of cases. 10 The anamnesis should confirm the lack of presence of the anomaly at birth, the occurrence of a proliferation and involution phase with the associated presence of volume changes, and the lack of pain or secretion in cases where no ulceration of the anomaly has occurred. At physical examination, increase of resilience and increase followed by decrease of volume over time, lack of souffles, ''thrill'' or pulsations, lack of flebolits, and lack of hypertrophy or hypotrophy are to be observed, as expected in cases of IH. 3, 10 As Frieden et al 13 stressed, the 5 risk factors of early age malignancies suggested by Knight and Reiner 14 and used by Coffin and Dehner 15 largely overlap with the diagnostic clues for IH. As such, an onset in the neonatal period, a history of rapid or progessive growth, skin ulceration, location deep to the fascia, and a firm mass greater than 3 cm in diameter are clues that are congruent with both IH, and a malignancy. Rather than diagnostic clues, therefore, Frieden et al 13 suggested 5 common themes regarding IH. First, an IH typically presents and increases during the first 6 mionths of life although a precursor lesion may present at birth. 5 Like presence at birth or growth in uteri, occurrence or growth after the age of 1 year should be considered alarming clues. We add that, in cases where the congenital tumor has a vascular appearance, the differential diagnosis should also include the rapidly involuting and non-involuting congenital hemangiomas (RICH and NICH). Unlike IH, RICH and NICH both have their growth phase in uteri and reach their maximum size before or at birth. 16 Subsequently, a RICH involutes rapidly by 6 to 10 months, whereas a NICH does not involute at all. But even in these cases, biopsies are still needed to rule out other neoplasms although typical sonographic features are described. 17 Second, Frieden et al 13 stressed that the clinical appearance of vascularity cannot be assumed to indicate the diagnosis of IH. For example, telangiectasias may be seen as a precursor lesion of IH, in the late involution stage or at the borders of the IH but do not predominately cover the surface of typical IH (Fig. 1) . We would further add that signs of pain, continuous bleeding or ulcerations, and rapid growth of the tumor that is incongruent with the natural growth of the child are indications for referral. 1, 3, 18 Third, multiple IHs mostly occur superficial and in the first few weeks of life. Deeper located multiple anomalies should raise alarm. Fourth, IHs may feel firm on palpation during the proliferation phase and softer during the regression phase. Regardless of the depths of their location, they never feel rock hard or fixed to the underlying fascia. Aberrant findings on palpation necessitate additional evaluation. Finally, we agree with Frieden that MR or ultrasonographic findings of high vascular flow cannot be assumed to support the diagnosis of IH and that, ultimately, an incisional or excisional biopsy may be needed to adequately reach the diagnosis.
In all cases where anamnesis and physical examination does not unequivocally indicate the diagnosis of IH, as well as in all cases where the initially consulted phycisian lacks adequate expertise with IH, the child should be referred to an experienced vascular anomaly team to rule out differential diagnoses (Fig. 8) . Still, additional imaging investigations may indeed not be helpful to differentiate IH from malignant tumors as is confirmed in our study. 18, 19 Because of its noninvasive nature and low costs, ultrasonography may be suitable as a first-line screening tool to discriminate IH from other soft-tissue tumors, 3, 20 but even an experienced ultrasonographer can have trouble distinguishing an IH. 20, 21 Likewise, MRI may be useful to differentiate 
between an IH and a vascular malformation, 22, 23 but cannot be conclusive as to whether a lesion is benign or malign. 24 At best, it can guide the biopsy to make a definite diagnosis by differentiating necrosis from solid tissue. 25 The accurateness of interpretation of such additional imaging studies, moreover, correlates with accurateness of the clinical findings. 23 In cases where the anamnesis and physical symptoms are incorrectly interpreted, the imaging studies are likely to be misinterpreted as well. Because MRI may not be conclusive regarding the diagnosis in these cases, the main reason to make one before biopsy is to document the extension of the lesion to guide further treatment. 25 Although a biopsy is indicated to rule out malignancies in cases where the diagnosis remains equivocal following history, physical examination, and imaging, sufficient expertise is required to differentiate between IH, other vascular anomalies, and a malignant vascular lesion. 19, 26, 27 Diagnostic Pitfalls in Our 7 Cases
In our study, we found 7 children with a malignancy. The initial diagnosis of IH, rather then malignancy, was incorrectly reached in these 7 children at various stages of the diagnostic pathway of anamnesis, physical examination, and additional investigations (eg, ultrasonography or MRI). Structured, thorough anamnesis and physical examination based on knowledge of the standard course of an IH would have led to the conclusion that these lesions could not have been IH. In 2 children (cases A and C), the age of onset (60, respectively, 20 months) had not been consistent with that of an IH (Table 4) . In 3 children (cases D, E, and G), the anomaly was full grown at birth and not persistent with one of the minor skin precursors of IH. In 2 children (cases A and B), the lack of proliferation phase did not agree with this diagnosis. In the 1 remaining child (case F), the anomaly did mimic an IH, but long-standing ulceration and the firmness of the tumor raised the suspicion of our team.
When anamnesis and physical examination are inconclusive, additional investigations may offer complementary information. Except for pathological examination of biopsies, however, these proved not to have helped to reach the definitive diagnosis in our series.
We conclude that early age malignant tumors can mimic benign IH and add 2 malignancies to the differential diagnosis of IH. Additional steps toward a definitive diagnosis must be taken in cases where the course of an anomaly that looks like an IH does not fit the standard clinical course of an IH. In cases where a malignancy cannot be ruled out, a biopsy needs to be examined by a pathologist who is experienced in vascular anomalies.
